⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 11, 2020JAMA

Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus

David L. Swerdlow Lyn Finelli

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Clinical Characteristics of Patients With 2019 Novel Coronavirus (2019-nCoV)–Infected Pneumonia in Wuhan, China

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Swerdlow et al. (2020) studied this question.

synapsesocial.com/papers/6a8d1655ddd1d62a24c56ca6 https://doi.org/10.1001/jama.2020.1960

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

12009 H1N1 Influenza Pandemic: Field and Epidemiologic Investigations in the United States at the Start of the First Pandemic of the 21st CenturyOriginal Research · 2010 · 40 citations
2Model Parameters and Outbreak Control for SARSOriginal Research · 2004 · 232 citations
3Middle East Respiratory Syndrome Coronavirus TransmissionOriginal Research · 2020 · 233 citations
4Middle East Respiratory Syndrome (MERS)Original Research · 2016 · 40 citations
5Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobilityOriginal Research · 2009 · 303 citations
6Implementation of Single-Pill Combination Therapy Through Team-Based Care for Hypertension Control in Resource-Constrained SettingsJAMA · 2026
7Low-Voltage Area Ablation for Persistent Atrial FibrillationJAMA · 2026
8Implementation of Single-Pill Combination Therapy Through Team-Based Care for Hypertension Control in Resource-Constrained SettingsJAMA · 2026
9Low-Voltage Area Ablation for Persistent Atrial FibrillationJAMA · 2026
10Percutaneous Coronary Intervention and Long-Term Outcomes in Stable Coronary Artery DiseaseJAMA · 2026

More from Pfizer (United States)

More from Merck & Co., Inc., Rahway, NJ, USA (United States)